Silenseed is a biopharmaceutical company that focuses on the development of cancer therapies.
Business Model:
Revenue: $0
Employees: 51-200
Address: PO Box 12000
City: Jerusalem
State: jerusalem district
Zip: 9112001
Country: IL
Silenseed is a clinical stage biopharmaceutical company that develops proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The company’ novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company’s pipeline are pancreatic cancer, prostate cancer and certain brain cancers.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2021 | Equity | $7.8M |
Guangzhou Sino-Israel Bio-Industry Investment Fund |
4/2014 | Venture Round | $500k | 3/2014 | Equity | $500k | 8/2017 | Venture Round | $10M | 12/2020 | Series A | 1 | - |
Laursen van Swieten Laursen van Swieten |
12/2020 | Series A | 1 | - |
Laursen van Swieten Laursen van Swieten |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|